Compton Capital Management Inc Bristol Myers Squibb CO Transaction History

Compton Capital Management Inc

$4.32 Billion
Q2 2023

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $1.11 Million - $1.26 Million	-16,885 Reduced 54.32%	14,199 $984,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $330,073 - $390,853	-4,820 Reduced 13.42%	31,084 $2.24 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $261 - $154,602	-2,012 Reduced 5.31%	35,904 $2.55 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $1.6 Million - $1.76 Million	-22,065 Reduced 36.79%	37,916 $2.92 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $79,924 - $95,836	-1,300 Reduced 2.12%	59,981 $4.38 Million
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $21,452 - $25,008	-400 Reduced 0.65%	61,281 $3.82 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $20,709 - $24,258	-350 Reduced 0.56%	61,681 $3.65 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $68,101 - $74,162	-1,100 Reduced 1.74%	62,031 $4.15 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $35,604 - $40,044	-600 Reduced 0.94%	63,131 $3.99 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $23,096 - $26,172	-400 Reduced 0.62%	63,731 $3.95 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $63,058 - $69,876	-1,098 Reduced 1.68%	64,131 $3.87 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $26,861 - $31,404	490 Added 0.76%	65,229 $3.84 Million
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $49,648 - $72,150	-1,070 Reduced 1.63%	64,739 $3.61 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.47 Million - $1.92 Million	29,890 Added 83.22%	65,809 $4.22 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $6,415 - $7,606	-150 Reduced 0.42%	35,919 $1.82 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $26,772 - $29,604	600 Added 1.69%	36,069 $1.64 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $5,414 - $6,456	-120 Reduced 0.34%	35,469 $1.69 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $75,578 - $98,006	-1,550 Reduced 4.17%	35,589 $1.85 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $7,427 - $9,258	147 Added 0.4%	37,139 $2.06 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $73,402 - $84,500	-1,225 Reduced 3.21%	36,992 $2.34 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $12,287 - $13,396	205 Added 0.54%	38,217 $2.34 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $71,799 - $82,862	1,300 Added 3.54%	38,012 $2.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	36,712	36,712 $2.05 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.33 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.46 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.58 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Account